122 related articles for article (PubMed ID: 37871880)
1. Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.
He X; Cui J; Ma H; Abuduaini N; Huang Y; Tang L; Wang W; Zhang Y; Wang Y; Lu W; Feng B; Huang J
Biochem Pharmacol; 2023 Dec; 218():115868. PubMed ID: 37871880
[TBL] [Abstract][Full Text] [Related]
2. Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer.
Wang W; Wu Y; Chen S; Liu X; He J; Wang S; Lu W; Tang Y; Huang J
Phytother Res; 2021 Jan; 35(1):463-476. PubMed ID: 32779300
[TBL] [Abstract][Full Text] [Related]
3. c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming.
Zhang Q; Cui K; Yang X; He Q; Yu J; Yang L; Yao G; Guo W; Luo Z; Liu Y; Chen Y; He Z; Lan P
Clin Transl Med; 2023 Jan; 13(1):e1164. PubMed ID: 36629054
[TBL] [Abstract][Full Text] [Related]
4. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
5. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
6. IMPDH2 forms spots at branching sites and distal ends of astrocyte stem processes.
Toyoda S; Handa T; Yong H; Takahashi H; Shiwaku H
Genes Cells; 2024 Feb; 29(2):150-158. PubMed ID: 38009721
[TBL] [Abstract][Full Text] [Related]
7. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.
Liao LX; Song XM; Wang LC; Lv HN; Chen JF; Liu D; Fu G; Zhao MB; Jiang Y; Zeng KW; Tu PF
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5986-E5994. PubMed ID: 28674004
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1/2.
Liu SS; Li JS; Xue M; Wu WJ; Li X; Chen W
Int J Biol Sci; 2023; 19(8):2599-2612. PubMed ID: 37215997
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
11. Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
He Y; Mou Z; Li W; Liu B; Fu T; Zhao S; Xiang D; Wu Y
Int J Colorectal Dis; 2009 Nov; 24(11):1271-9. PubMed ID: 19597826
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma.
Jia X; Liu Y; Cheng Y; Wang Y; Kang H; Ma Z; Chen K
J Clin Lab Anal; 2022 May; 36(5):e24416. PubMed ID: 35403278
[TBL] [Abstract][Full Text] [Related]
13. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
[TBL] [Abstract][Full Text] [Related]
15. IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex.
Pua KH; Stiles DT; Sowa ME; Verdine GL
Cell Rep; 2017 Jan; 18(2):432-442. PubMed ID: 28076787
[TBL] [Abstract][Full Text] [Related]
16. IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
Garat A; Cauffiez C; Hamdan-Khalil R; Glowacki F; Devos A; Leclerc J; Lionet A; Allorge D; Lo-Guidice JM; Broly F
Genet Test Mol Biomarkers; 2009 Dec; 13(6):841-7. PubMed ID: 19810816
[TBL] [Abstract][Full Text] [Related]
17. Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton.
Lake JI; Avetisyan M; Zimmermann AG; Heuckeroth RO
Dev Biol; 2016 Jan; 409(1):152-165. PubMed ID: 26546974
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells.
Bremer S; Rootwelt H; Bergan S
Clin Chem; 2007 Jun; 53(6):1023-9. PubMed ID: 17463174
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
20. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
